Search Results 241-250 of 6265 for younkin

  1. 18 Months Later - Your Impact Development

    We did the genetic testing and found out, in fact, Andrew was not able to break down the medications the way most individuals would. Because of this, the ...

  2. A Study Evaluating Effectiveness and Safety of FFX Versus Combination of CPI-613 with mFFX in Patients with Metastatic Adenocarcinoma of the Pancreas - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of Folfirinox (FFX) versus CPI-613 + Modified Folfirinox (mFFX) in patients with ...

  3. A Study to Evaluate Pevonedistat and Venetoclax Plus Azacitidine in Adults with Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy - Mayo Clinic

    The purpose of this study is to determine whether the combination of pevonedistat + venetoclax + azacitidine improves event-free survival (EFS) compared with ...

  4. Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS - Mayo Clinic

    Mocetinostat is an orally administered histone deacetylase (HDAC) inhibitor. Azacitidine is a hypomethylating agent (HMA) used to treat MDS. In this study, ...

  5. A Study of Poziotinib in Patients with NSCLC With EGFR or HER2 Exon 20 Insertion Mutation - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and the safety/tolerability of poziotinib in patients with NSCLC exon 20 insertion mutations.

  6. A Phase 1-2 Multi-Center Study Evaluating Axicabtagene Ciloleucel in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) - Mayo Clinic

    This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-C19, an autologous anti-CD19 chimeric antigen ...

  7. A Study to Create a Patient Decision Aid for Familial Hypercholesterolemia to Promote Shared Decision Making Between Patients and Physicians - Mayo Clinic

    The purpose of this study is to assist patients and clinicians in discussing the potential benefits and side effects of treatment of familial ...

  8. Publications - Pankaj Shah, M.D. - Mayo Clinic

    Navratil P, Sahi SS, Smith BH, Denic A, Issa NS, Heyer D, Marzlof T, Shaik AA, Schinstock CA, Ghanem OM, Stegall MD, Lerman LO, Shah M, Shah P, Kudva YC, ...

  9. Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL - Mayo Clinic

    Pre-clinical and mechanistic studies support that azacitidine may modulate pathways that enable birinapant-mediated anti-tumor activity. Participation ...

  10. Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...